Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection.
Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection.
复制标题
中东呼吸综合征冠状病毒感染的临床进展和细胞因子谱。
DOI:
10.3346/jkms.2016.31.11.1717
复制
发表时间:
2016-11
影响因子:
4.5
通讯作者:
Oh MD
中科院分区:
文献类型:
--
作者:
Kim ES;Choe PG;Park WB;Oh HS;Kim EJ;Nam EY;Na SH;Kim M;Song KH;Bang JH;Park SW;Kim HB;Kim NJ;Oh MD
Clinical progression over time and cytokine profiles have not been well defined in patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection. We included 17 patients with laboratory-confirmed MERS-CoV during the 2015 outbreak in Korea. Clinical and laboratory parameters were collected prospectively. Serum cytokine and chemokine levels in serial serum samples were measured using enzyme-linked immunosorbent assay. All patients presented with fever. The median time to defervescence was 18 days. Nine patients required oxygen supplementation and classified into severe group. In the severe group, chest infiltrates suddenly began to worsen around day 7 of illness, and dyspnea developed at the end of the first week and became apparent in the second week. Median time from symptom onset to oxygen supplementation was 8 days. The severe group had higher neutrophil counts during week 1 than the mild group (4,500 vs. 2,200/µL, P = 0.026). In the second week of illness, the severe group had higher serum levels of IL-6 (54 vs. 4 pg/mL, P = 0.006) and CXCL-10 (2,642 vs. 382 pg/mL, P < 0.001). IFN-α response was not observed in mild cases. Our data shows that clinical condition may suddenly deteriorate around 7 days of illness and the serum levels of IL-6 and CXCL-10 was significantly elevated in MERS-CoV patients who developed severe diseases.
登录
查看更多内容
影响因子:
4.5
作者:
Oh, Myoung-don;Choe, Pyoeng Gyun;Kim, Nam Joong
通讯作者:
Kim, Nam Joong
影响因子:
6.4
作者:
Chi, Ying;Zhu, Yefei;Zhou, Minghao
通讯作者:
Zhou, Minghao
影响因子:
4.3
作者:
Korea Centers for Disease Control and Prevention
通讯作者:
Korea Centers for Disease Control and Prevention
DOI:
10.1016/j.ijid.2014.09.003
发表时间:
2014-12
期刊:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
影响因子:
--
作者:
Saad M;Omrani AS;Baig K;Bahloul A;Elzein F;Matin MA;Selim MA;Al Mutairi M;Al Nakhli D;Al Aidaroos AY;Al Sherbeeni N;Al-Khashan HI;Memish ZA;Albarrak AM
通讯作者:
Albarrak AM
DOI:
10.1056/nejmoa1306742
发表时间:
2013-08-01
期刊:
The New England journal of medicine
影响因子:
--
作者:
Assiri A;McGeer A;Perl TM;Price CS;Al Rabeeah AA;Cummings DA;Alabdullatif ZN;Assad M;Almulhim A;Makhdoom H;Madani H;Alhakeem R;Al-Tawfiq JA;Cotten M;Watson SJ;Kellam P;Zumla AI;Memish ZA;KSA MERS-CoV Investigation Team
通讯作者:
KSA MERS-CoV Investigation Team